Factor VIIa in Acute Intracerebral Haemorrhage

• Status: Completed
• Trial end date: 2007-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial is conducted in Japan. The purpose of this trial is to evaluate the safety and preliminary efficacy of Activated Recombinant Factor VII (NN-007) in patients with acute intracerebral haemorrhage.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S

Criteria

Inclusion Criteria:

• Spontaneous ICH

Exclusion Criteria:

• Time of ICH onset > 3 hours

• Patients with secondary ICH

• Pre-existing disability

• Hemophilia